Anzeige
Mehr »
Login
Samstag, 19.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Diese Aktie steigt um 225%! Ist ein Kupfer-Engpass im Gange?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
282 Leser
Artikel bewerten:
(1)

ClickStream Corporation: ClickStream's HeyPal App Experiencing Untamed Growth by Reaching Over 4,200,000 Messages, 865,000 Translations, 279,000 Downloads 186,000 Likes and 22,000 Posts within 7 Months of Beta Launch

BEVERLY HILLS, CA / ACCESSWIRE / September 1, 2021 / ClickStream Corp. (OTC PINK:CLIS) a technology company focused on developing apps and digital platforms that disrupt conventional industries announces its subsidiary Nebula Software Corp.'s HeyPal app has received over 4,200,000 messages, 865,000 translations, 279,000 downloads, 186,000 likes and 22,000 posts since the app was beta-launched less than seven months ago in the iOS App Store.

During HeyPal's Beta iOS launch from February 8th, 2021, through July 14th, 2021, HeyPal gained 34,000 downloads. Since its Global iOS launch on July 15th, 2021, HeyPal has gained an additional 245,000 downloads. HeyPal now has over 279,000 downloads. Other key HeyPal metrics:

  • 66% user loyalty for new users (opens the app 3 times within 24hrs and stays at least a minute per session)
  • 34% of users are organic downloaders finding the app on App Store Search and App Store Browse
  • 75,522 new downloads in August
  • Users do 7.76 sessions per day on average

"HeyPal continues to track to our internally planned engagement metrics. We are excited about our upcoming Android launch this Fall which will open up HeyPal to the majority of the worldwide market," stated Frank Magliochetti, CEO of ClickStream.

ClickStream is on track to release the Android version of HeyPal worldwide this Fall, making the app available to many more users across the globe. Smartphones running the Android operating system held an 87 percent share of the global market in 2019 and expected to increase over the forthcoming years. The mobile operating system developed by Apple (iOS) has a 13 percent share of the market according to Statista. For further information, please see https://www.statista.com/statistics/272307/market-share-forecast-for-smartphone-operating-systems/.

ABOUT CLICKSTREAM CORPORATION
ClickStream is a technology company focused on developing apps and digital platforms that disrupt conventional industries. The company is currently marketing and developing WinQuik and HeyPal respectively. For more information, please visit them online at https://clickstream.technology/ and follow them on social media; Twitter at https://twitter.com/ClickstreamC and Instagram at https://www.instagram.com/clickstreamcorp/.

WinQuik, is a free-to-play synchronized mobile app and digital gaming platform. The platform is designed to enable WinQuik users to have fun, interact and compete in order to win real money and prizes. For more information, please visit them online at http://www.winquik.com/ and follow them on social media; Twitter at https://twitter.com/winquikapp and Instagram at https://www.instagram.com/winquiktrivia/.

HeyPal, by way of ClickStream subsidiary Nebula Software Corp., is a language learning app that focuses on "language exchanging" between users around the world. For more information, please visit them online at https://www.heypalapp.com/ and follow them on social media; Twitter at https://twitter.com/HeypalA and Instagram at https://instagram.com/heypalapp/.

Nifter, by way of ClickStream subsidiary Rebel Blockchain Inc., is a music NFT marketplace that allows artists to create, sell and discover unique music and sound NFTs on the Nifter marketplace. For more information, please visit them online at https://Nifter.io and follow them on social media; Twitter at https://twitter.com/Nifter7 and Instagram at https://www.instagram.com/nifter.io/.

SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

FOR MEDIA INQUIRIES, PLEASE CONTACT:
Heather Krug
Heather@heatherkrug.com

SOURCE: ClickStream Corporation



View source version on accesswire.com:
https://www.accesswire.com/662334/ClickStreams-HeyPalTM-App-Experiencing-Untamed-Growth-by-Reaching-Over-4200000-Messages-865000-Translations-279000-Downloads-186000-Likes-and-22000-Posts-within-7-Months-of-Beta-Launch

© 2021 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.